Imatinib is an antineoplastic drug; that is, it is used to treat cancer. It is used for chronic myeloid leukemia (CML), acute lymphocytic leukemia (ALL), gastrointestinal tumors, chronic eosinophilic leukemia (CEL), and hypereosinophilic syndrome. Its common side effects include muscle pain, headache, vomiting, and diarrhea.
Imatinib - Mechanism of Action, Indications, Dosage, and Adverse Drug Reactions
Imatinib is an oral targeted therapy that targets tyrosine kinases and represents a therapeutic breakthrough in cancer treatment.
